Walgreens Allowed Iffy Opioid Orders, SF Says At Trial Wrap
By Bonnie Eslinger ( July 12, 2022, 10:27 PM EDT) -- Walgreens didn't maintain effective controls to prevent prescription opioids from being diverted to individuals for illicit uses, lawyers for San Francisco told a federal judge Tuesday during closing trial arguments that followed an announcement that defendants Allergan and Teva struck settlements worth nearly $58 million to exit the litigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.